Randall and colleagues demonstrated that the concentration of heparin cofactor II-thrombin complex (HCII-T) in serum was highly elevated in MPS I, II, and VI patients with respect to controls and they evidenced that HCII-T may reflect the disease severity, as well as the response to treatment [255]. The gene discussed is SERPIND1; the disease is Scheie syndrome.